Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients. - Wikidata - awgldk - TriplyDB

Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients.

Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients.

http://www.wikidata.org/entity/Q36785835

about

Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae Minocycline as A Substitute for Doxycycline in Targeted Scenarios: A Systematic Review Early Additional Immune-Modulators for Mycoplasma pneumoniae Pneumonia in Children: An Observation Study.Epidemiological comparison of three Mycoplasma pneumoniae pneumonia epidemics in a single hospital over 10 years Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients.Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy Cluster of macrolide-resistant Mycoplasma pneumoniae infections in Illinois in 2012.Treating paediatric community-acquired pneumonia in the era of antimicrobial resistance.Mycoplasma pneumoniae 23S rRNA A2063G mutation does not influence chest radiography features in children with pneumonia.Mycoplasma pneumoniae from the Respiratory Tract and Beyond.Intracellular Pharmacokinetics of Antibacterials and Their Clinical Implications.Mechanism of resistance acquisition and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.Comparison of efficacy of antimicrobial agents among hospitalized patients with Mycoplasma pneumoniae pneumonia in Japan during large epidemics of macrolide-resistant M. pneumoniae infections: A nationwide observational study.Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance.Characteristics of Mycoplasma pneumoniae infection identified on culture in a pediatric clinic.Mycoplasma pneumoniae: A Potentially Severe Infection.

P2860

Q26744683-B01F13F9-9D01-4779-BB20-159D951D1870 Q26771470-EC302B2A-3CA5-4466-9376-327FFE891B27 Q34838916-817E04DC-5AA8-4590-A7D2-676E5BA38266 Q35782507-F491FEEB-CEA5-4E76-97B3-A885DB27490F Q36306172-021426F5-2CB0-49D5-A461-D02E0055F268 Q37263838-ADD87789-6D5D-4A32-93A0-36AD77CBA2E7 Q37470551-D3030BA2-4A11-41E7-B9AB-CFC42CE3D20F Q38170557-1C5C4626-8332-4E8F-B0AD-EA9559885B82 Q38651308-7554B13B-C200-47A6-8B5C-F56F101DEE52 Q39327219-465633AB-4297-4F18-938A-177F7792F815 Q39390126-BAC9EF55-D6EA-41B5-9697-8CD838EB61DC Q39424555-BEBFDE78-F27D-4633-BFC1-B6FCA4FD9A54 Q41987270-39D9A078-9666-48AB-9871-D05931CB5540 Q50047524-29A8C902-88A8-449E-BFC8-5D5213D7C677 Q51595534-96D68174-0017-428E-A2B6-FBD76E5CF38E Q51810584-EB0A0E45-BA3F-4D74-96C4-6DB30A0DDF8A Q55314495-7F724189-9D62-4BAD-BA10-5EA110D8CB71

P2860

Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients.

http://www.wikidata.org/entity/Q36785835

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Therapeutic efficacy of macrol ...... eumonia in pediatric patients.

@en

type

label

Therapeutic efficacy of macrol ...... eumonia in pediatric patients.

@en

prefLabel

Therapeutic efficacy of macrol ...... eumonia in pediatric patients.

@en

P1433

Q36785835-B2C41298-4415-4699-AB53-03FDF0CB654D

P1476

Q36785835-B51BD96D-B132-4B91-8F29-FF7C7A151342

P2093

Q36785835-136E1B94-3BCF-4340-B778-6F327413DA7E

Q36785835-19711B7F-8C44-41FE-A890-63AB7C299DE3

Q36785835-24A7B042-C361-4CA8-8B1D-733B4901CFA2

Q36785835-438C8781-E929-4D28-B83B-99837DD56EB3

Q36785835-65902472-48CE-4855-B4FB-3806E9DECE4B

Q36785835-67901101-882C-43AC-8761-FB7BBB6DF0DA

Q36785835-7529CA6A-5CB7-4020-9E26-5E791C7A6629

Q36785835-7A1DC89A-8B2E-4E45-99D9-7639A3FCC760

Q36785835-8BD4EAC0-F42E-4154-9BD0-D4850EDBFA95

Q36785835-A93624D7-AC50-4FDB-820D-EF8575423881

P2860

Q36785835-11ABD7D5-CFE6-4470-B999-1B2C68A164BF

Q36785835-39B710BB-4517-4590-B0EA-EBB9C0A41AB3

Q36785835-3F278EA7-D66E-4B5D-A8EF-61B3F2630C41

Q36785835-4DF65146-69E7-4A7F-9995-F1E3B80BAB9C

Q36785835-593DCB9F-F48C-41BC-8113-84C3A85828B3

Q36785835-5C2EB7D1-C116-4A9B-A27D-7EB365B9784B

Q36785835-70073904-BB59-41C2-A1BF-BCF2E2F988A2

Q36785835-7400F6F6-5D90-4917-9C64-F71C55227EE6

Q36785835-7DD706FB-36F1-4040-A9F2-E11D4A2673E6

Q36785835-7DE1FE7B-9C9E-45EF-AB73-DA82EA4DF7D3

P304

Q36785835-4A44A6C9-5D2A-4EC0-AA96-8851A0250651

P31

Q36785835-FD112D17-50D0-4E55-9A86-3B86D1C90FA4

P356

Q36785835-F8C208A0-1887-4299-B8C7-E3BC340E084F

P407

Q36785835-C44C9BB2-70D2-46F3-AA78-8A404F57A2D1

P433

Q36785835-F13EE0C6-7F28-4B75-A4CB-27BC45314C09

P478

Q36785835-2BC32898-2539-4073-962E-B34A4ED4E35F

P577

Q36785835-055C364D-EB27-43A2-A1E2-0F1420C9C002

P5875

Q36785835-A6E1EC3F-E542-41FF-BA32-3370C56A0DF6

P698

Q36785835-E4A2CAAE-64C3-401D-BAF6-02229079C521

P932

Q36785835-F806D610-B945-4375-92A7-E406C00700F3

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Therapeutic efficacy of macrol ...... eumonia in pediatric patients.

@en

P2093

Aki Saito

http://www.w3.org/2001/XMLSchema#string

Atsushi Kato

http://www.w3.org/2001/XMLSchema#string

Eisuke Kondo

http://www.w3.org/2001/XMLSchema#string

Hideto Teranishi

http://www.w3.org/2001/XMLSchema#string

Hiroto Akaike

http://www.w3.org/2001/XMLSchema#string

Kazunobu Ouchi

http://www.w3.org/2001/XMLSchema#string

Kihei Terada

http://www.w3.org/2001/XMLSchema#string

Kozo Kawasaki

http://www.w3.org/2001/XMLSchema#string

Mika Kubo

http://www.w3.org/2001/XMLSchema#string

Naoyuki Miyashita

http://www.w3.org/2001/XMLSchema#string

P2860

Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia.

Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children.

Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae.

Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.

In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas

Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010

An outbreak of Mycoplasma pneumoniae caused by a macrolide-resistant isolate in a nursery school in China.

Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia

Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.

Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia.

P304

2252-2258

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00048-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235786784

http://www.w3.org/2001/XMLSchema#string

P698

23459497

http://www.w3.org/2001/XMLSchema#string

P932

3632908

http://www.w3.org/2001/XMLSchema#string